As of 2026-08-21, Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) has a 3-month relative strength percentile of 67 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 53. The current market Stance is 49.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 1.4%, relative volume 0.40×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
No SEC filings on file for this ticker. Fundamentals section requires EDGAR coverage.
TAK is held by 5 ETFs as of May 2026. Top owner: AVDE at 0.05% weight, $8M notional. Top 3 carry $12M.
Held by 12 ETFs · $104M across latest filings · largest weight 3.15% (PPH).
Top 5 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| AVDE | 0.05% | $8M | — |
| APIE | 0.26% | $3M | −0.03 pp |
| JSTC | 0.33% | $1M | −0.09 pp |
| GINX | 0.80% | $760K | −0.13 pp |
| AVSD | 0.05% | $249K | −0.01 pp |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TAK Jan avg: 3.81% median: 1.80% win: 100% σ: 4.50% n: 4 2022-04-12 → 2026-07-31 | TAK Feb avg: 3.38% median: 3.77% win: 50% σ: 5.72% n: 4 2022-04-12 → 2026-07-31 | TAK Mar avg: 1.13% median: 0.98% win: 50% σ: 5.29% n: 4 2022-04-12 → 2026-07-31 | TAK Apr avg: -2.82% median: -1.82% win: 40% σ: 5.12% n: 5 2022-04-12 → 2026-07-31 | TAK May avg: -1.87% median: -1.70% win: 20% σ: 2.71% n: 5 2022-04-12 → 2026-07-31 | TAK Jun avg: -0.63% median: -0.82% win: 40% σ: 2.40% n: 5 2022-04-12 → 2026-07-31 | TAK Jul avg: 0.76% median: 4.06% win: 60% σ: 7.83% n: 5 2022-04-12 → 2026-07-31 | TAK Aug avg: 2.89% median: 4.10% win: 75% σ: 6.85% n: 4 2022-04-12 → 2026-07-31 (current) | TAK Sep avg: -3.01% median: -3.42% win: 25% σ: 2.69% n: 4 2022-04-12 → 2026-07-31 | TAK Oct avg: -5.08% median: -5.08% win: 25% σ: 6.26% n: 4 2022-04-12 → 2026-07-31 | TAK Nov avg: 5.12% median: 5.67% win: 75% σ: 5.79% n: 4 2022-04-12 → 2026-07-31 | TAK Dec avg: 3.02% median: 3.38% win: 75% σ: 4.92% n: 4 2022-04-12 → 2026-07-31 |